Viewing Study NCT00479232

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:38 PM

Ignite Modification Date: 2026-01-09 @ 11:21 AM

Study NCT ID: NCT00479232

Status: COMPLETED

Last Update Posted: 2015-09-21

First Post: 2007-05-24

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)

Sponsor: Merck Sharp & Dohme LLC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module